ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements ...
The prevalence of performance-enhancing drugs (PEDs) in MMA has become an escalating concern within the fighter community.
Magomed Ankalaev’s victory over Alex Pereira at UFC 313 seemingly disrupted the potential superfight between the Brazilian ...
New agents targeting endocrine therapy and CDK4/6 resistance in hormone receptor–positive breast cancer are in development.
India Today on MSN3d
Struggling to conceive? How endometriosis may be affecting your fertilityEndometriosis may affect fertility in a variety of ways. Tubal blockage results from scarring, causing adhesions that block the egg's pathway to sperm. Pelvic inflammatory disease leads to chronic ...
Immunotherapy advances in triple-negative breast cancer drive personalized treatments with immune checkpoint inhibitors, aiding subtype identification and new combination therapy developments.
The National on MSN3d
Changing the fertility conversation: UAE experts on what to know about reproductive healthHow do we talk about the rise of infertility without creating anxiety? When is it appropriate to broach topics such as egg ...
Trial 4: A multinational European trial comparing sorafenib-plus-docetaxel or -letrozole versus docetaxel- or letrozole-plus-placebo as first-line therapy in patients with MBC. Potential trials ...
PR+ breast cancer responds well to hormone therapy, underscoring the need for molecular insight and targeted treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback